Table 1 from Izalontamab (SI-B001), a Novel EGFRxHER3 Bispecific Antibody in Patients with Locally Advanced or Metastatic Epithelial Tumor: Results from First-in-Human Phase I/Ib Study
收藏Figshare2025-11-03 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_1_from_Izalontamab_SI-B001_a_Novel_EGFRxHER3_Bispecific_Antibody_in_Patients_with_Locally_Advanced_or_Metastatic_Epithelial_Tumor_Results_from_First-in-Human_Phase_I_Ib_Study/30516598
下载链接
链接失效反馈官方服务：
资源简介：
Baseline demographic and clinical characteristics.
创建时间：
2025-11-03
